Factors, enablers and challenges for COVID-19 vaccine development

JL Excler, M Saville, L Privor-Dumm, S Gilbert… - BMJ Global …, 2023 - gh.bmj.com
The COVID-19 pandemic triggered a sense of vulnerability and urgency that led to
concerted actions by governments, funders, regulators and industry to overcome traditional …

[HTML][HTML] Current evidence in SARS-CoV-2 mRNA vaccines and post-vaccination adverse reports: knowns and unknowns

DS Mouliou, E Dardiotis - Diagnostics, 2022 - mdpi.com
The novel mRNA vaccinations against COVID-19 are gaining worldwide attention for their
potential efficacy, as well as for the diagnosis of some post-vaccination-reported adverse …

[HTML][HTML] Neurological adverse reactions to SARS-CoV-2 vaccines

J Finsterer - Clinical Psychopharmacology and Neuroscience, 2023 - ncbi.nlm.nih.gov
SARS-CoV-2 vaccines are not free of side effects and most commonly affect the central or
peripheral nervous system (CNS, PNS). This narrative review aims to summarise recent …

[HTML][HTML] Fatal exacerbations of systemic capillary leak syndrome complicating coronavirus disease

PC Cheung, AR Eisch, N Maleque… - Emerging Infectious …, 2021 - ncbi.nlm.nih.gov
We report 2 fatal exacerbations of systemic capillary leak syndrome (SCLS), also known as
Clarkson disease, associated with coronavirus disease (COVID-19) in the United States …

[HTML][HTML] Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance

R Ruggiero, N Balzano, R Di Napoli… - Frontiers in …, 2022 - frontiersin.org
Capillary leak syndrome (CLS) emerged as new adverse event after immunization (AEFI)
associated to COVID-19 vaccination. CLS is a rare condition characterized by increased …

[HTML][HTML] Fatal systemic capillary leak syndrome after SARS-CoV-2vaccination in patient with multiple myeloma

GJ Choi, SH Baek, J Kim, JH Kim… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
A young man with smoldering multiple myeloma died of hypotensive shock 2.5 days after
severe acute respiratory syndrome coronavirus 2 vaccination. Clinical findings suggested …

[HTML][HTML] Do we miss rare adverse events induced by COVID-19 vaccination?

Z Mohseni Afshar, A Tavakoli Pirzaman, JJ Liang… - Frontiers in …, 2022 - frontiersin.org
Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has
caused many complications, the invention of coronavirus disease 2019 (COVID-19) …

[HTML][HTML] Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination

J Robichaud, C Côté, F Côté - CMAJ, 2021 - Can Med Assoc
• Rare cases of systemic capillary leak syndrome (SCLS) have been reported worldwide
after vaccination with adenoviral vector and mRNA vaccines against SARS-CoV-2; a …

Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination

A Cole, R Thomas, N Goldman, K Howell… - Journal of …, 2022 - Elsevier
The largest world-wide vaccination rollout ever is currently underway to tackle the covid-19
pandemic. We report a case of diffuse cutaneous systemic sclerosis (SSc) in a 70-year-old …

[HTML][HTML] Immune Responses against SARS-CoV-2—Questions and Experiences

H Mangge, M Kneihsl, W Schnedl, G Sendlhofer… - Biomedicines, 2021 - mdpi.com
Understanding immune reactivity against SARS-CoV-2 is essential for coping with the
COVID-19 pandemic. Herein, we discuss experiences and open questions about the …